1. Home
  2. GURE vs GNPX Comparison

GURE vs GNPX Comparison

Compare GURE & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GURE
  • GNPX
  • Stock Information
  • Founded
  • GURE 2006
  • GNPX 2009
  • Country
  • GURE China
  • GNPX United States
  • Employees
  • GURE N/A
  • GNPX N/A
  • Industry
  • GURE Major Chemicals
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GURE Industrials
  • GNPX Health Care
  • Exchange
  • GURE Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • GURE 7.3M
  • GNPX 6.1M
  • IPO Year
  • GURE 1992
  • GNPX 2018
  • Fundamental
  • Price
  • GURE $0.62
  • GNPX $0.30
  • Analyst Decision
  • GURE
  • GNPX Strong Buy
  • Analyst Count
  • GURE 0
  • GNPX 1
  • Target Price
  • GURE N/A
  • GNPX $10.00
  • AVG Volume (30 Days)
  • GURE 41.7K
  • GNPX 6.0M
  • Earning Date
  • GURE 11-19-2024
  • GNPX 05-13-2025
  • Dividend Yield
  • GURE N/A
  • GNPX N/A
  • EPS Growth
  • GURE N/A
  • GNPX N/A
  • EPS
  • GURE N/A
  • GNPX N/A
  • Revenue
  • GURE $12,802,982.00
  • GNPX N/A
  • Revenue This Year
  • GURE N/A
  • GNPX N/A
  • Revenue Next Year
  • GURE N/A
  • GNPX N/A
  • P/E Ratio
  • GURE N/A
  • GNPX N/A
  • Revenue Growth
  • GURE N/A
  • GNPX N/A
  • 52 Week Low
  • GURE $0.50
  • GNPX $0.22
  • 52 Week High
  • GURE $1.79
  • GNPX $4.09
  • Technical
  • Relative Strength Index (RSI)
  • GURE 40.26
  • GNPX 39.82
  • Support Level
  • GURE $0.65
  • GNPX $0.22
  • Resistance Level
  • GURE $0.78
  • GNPX $0.41
  • Average True Range (ATR)
  • GURE 0.07
  • GNPX 0.06
  • MACD
  • GURE -0.00
  • GNPX -0.00
  • Stochastic Oscillator
  • GURE 1.92
  • GNPX 25.00

About GURE Gulf Resources Inc. (NV)

Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: